Correlation Between Akari Therapeutics and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akari Therapeutics PLC and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Akari Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Pmv Pharmaceuticals.

Diversification Opportunities for Akari Therapeutics and Pmv Pharmaceuticals

-0.87

Correlation Coefficient

Akari Therapeutics  Pmv Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Akari and Pmv is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Akari Therapeutics and Pmv Pharmaceuticals

Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Pmv Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Akari Therapeutics PLC is 1.06 times less risky than Pmv Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Pmv Pharmaceuticals is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  89.00  in Pmv Pharmaceuticals on May 7, 2025 and sell it today you would earn a total of  55.00  from holding Pmv Pharmaceuticals or generate 61.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Akari Therapeutics PLC  vs.  Pmv Pharmaceuticals

Akari Therapeutics PLC

Risk-Adjusted Performance

Weakest

Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pmv Pharmaceuticals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Akari Therapeutics and Pmv Pharmaceuticals

The main advantage of trading using opposite Akari Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind Akari Therapeutics PLC and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..